NAD+ (nicotinamide adenine dinucleotide) is not a peptide and not a medication. It is a vital coenzyme required for virtually every redox reaction inside the human cell.
NAD+ plays a central role in cellular energy production, DNA repair, mitochondrial function, epigenetic regulation, and inflammatory control. In many ways, it acts as one of the core metabolic currencies of the body.
Research shows that NAD+ levels decline significantly with age — in some tissues by up to 50% by the age of 50–60. This decline is considered one of the recognized hallmarks of aging and is associated with mitochondrial dysfunction, impaired DNA repair, chronic inflammation, and reduced sirtuin activity.
In peptide-pen format, injectable NAD+ is used subcutaneously as a more practical alternative to intravenous NAD+ infusions, allowing easier long-term use in outpatient and home-based protocols.
NAD+ affects multiple biological systems simultaneously because it is deeply involved in fundamental cellular metabolism.
NAD+ is essential for glycolysis, the Krebs cycle, and oxidative phosphorylation inside mitochondria.
Without sufficient NAD+, ATP production — the primary source of cellular energy — becomes less efficient.
Restoring NAD+ levels may help support mitochondrial performance, stimulate mitophagy (the removal of damaged mitochondria), and improve cellular energy production.
Sirtuins are a family of NAD+-dependent enzymes involved in longevity and cellular resilience.
They participate in:
Many of the beneficial effects associated with calorie restriction, fasting, and exercise are believed to be mediated through increased NAD+ availability and subsequent sirtuin activation.
PARP enzymes are responsible for identifying and repairing damaged DNA.
These enzymes consume large amounts of NAD+ during the repair process.
With aging and chronic stress, DNA damage accumulates, PARP activity increases, and NAD+ stores may become depleted more rapidly.
Maintaining adequate NAD+ levels may help support both DNA repair mechanisms and healthy sirtuin function simultaneously.
One of the major contributors to NAD+ depletion during aging is increased activity of the CD38 enzyme.
CD38 actively breaks down NAD+, particularly within immune and inflammatory pathways.
This process is considered one of the key drivers of age-associated NAD+ deficiency.
NAD+ derivatives also participate in intracellular calcium signaling, which is essential for muscle contraction, nerve transmission, and hormone secretion.
Modern longevity protocols often combine injectable NAD+ for rapid replenishment with oral NMN or NR supplementation for maintenance support.
Research into injectable NAD+ therapy is ongoing, but several potential effects have already been described in clinical and experimental settings.
Many patients report increased energy levels and reduced fatigue within the first 1–2 weeks of therapy.
NAD+ protocols are being explored for support of memory, concentration, focus, and cognitive performance, particularly in adults over 45.
NAD+ is actively studied in the context of mitochondrial dysfunction, metabolic disorders, and neurodegenerative conditions.
By supporting sirtuin pathways and cellular repair mechanisms, NAD+ may help improve skin texture, barrier function, and overall skin quality.
NAD+-dependent pathways are linked to circadian rhythm regulation and healthy sleep architecture.
NAD+ therapy has also been explored as supportive care in recovery programs related to alcohol, nicotine, and substance dependence.
NAD+ may help regulate inflammatory signaling pathways, including NF-κB-related mechanisms associated with chronic inflammation.
Research also suggests potential benefits for insulin sensitivity, metabolic flexibility, and lipid metabolism.
NAD+ remains one of the most actively studied molecules in longevity medicine and cellular aging research.
While many mechanisms appear promising, ongoing human studies are still evaluating long-term clinical outcomes and optimal treatment strategies.
AICAR — a powerful mitochondrial combination: NAD+ provides the “fuel,” while AICAR activates the AMPK pathway, switching on mitochondrial biogenesis and fat-burning mechanisms. One of the most logical “mitochondrial stacks” of 2025–2026.
Sermorelin, CJC-1295 + Ipamorelin — classic anti-age combinations: GHRH secretagogues work through the GH/IGF-1 axis, while NAD+ supports mitochondria and sirtuins. A classic foundation for anti-age protocols after 45.
GHK-Cu, GLOW stack — for synergistic anti-age support of skin quality.
BPC-157 + TB-4 — in recovery-focused protocols: peptides support tissue regeneration, while NAD+ supports cellular energy production.
Tirzepatide, CagriSema, AOD-9604 — in weight management programs for preservation of muscle mass and mitochondrial function.
ARA-290 — when anti-age goals are combined with neuropathy-related support.
LL-37 — in post-viral and immune-support protocols.
Coenzyme Q10, L-carnitine, omega-3, vitamin D, magnesium, and B-complex vitamins (especially B3/niacin) — nutritional support for mitochondrial function and NAD+ biosynthesis.
NAD+ became one of the most discussed molecules in anti-age and longevity medicine during the 2020s, largely due to the work of David Sinclair (Harvard) and Shin-ichiro Imai (Washington University), along with other leading scientists.
From 2018–2020, NAD+ IV drips became increasingly popular in premium clinics across the United States, Europe, Dubai, and later Russia.
Between 2024–2026, there has been a noticeable shift from IV infusions toward subcutaneous injections and pen injectors. This significantly expanded accessibility, making long-term home-based protocols possible without losing medical supervision.
In Russia, NAD+ is now actively used in specialized anti-age and metabolic clinics, including pen-injector formats.
NAD+ has a very favorable safety profile, especially in subcutaneous formats when used in appropriate dosages.
NAD+ is a foundational molecule of cellular energy and longevity.
Unlike many compounds in modern peptide protocols, NAD+ does not have one narrow “target.” It is required by virtually every cell, in every tissue, at every age.
With age, NAD+ levels inevitably decline, and restoring the NAD+ pool is considered one of the ways to work with a fundamental hallmark of aging.
At the same time, it is important to maintain a realistic perspective:
In modern anti-age medicine, NAD+ is not viewed as a “magic molecule,” but rather as a foundation.
On top of this foundation, clinicians build protocols with growth hormone axis peptides (Sermorelin, CJC-1295), regenerative stacks (BPC-157 + TB-4, GLOW), mitochondrial activators (AICAR, MOTS-c), and weight management therapies (tirzepatide, CagriSema).
NAD+ supports the one thing without which none of these protocols can function optimally — cellular energy production.
You can schedule a consultation at Refresh Clinic through the clinic website or contact number.
We create personalized NAD+ protocols for anti-age and longevity support, chronic fatigue and post-viral recovery, weight management programs, metabolic support, and mitochondrial health.
This material is provided for informational purposes only and does not replace an in-person consultation with a physician.
Before starting therapy, age-appropriate cancer screening is recommended.
Self-injections and purchasing medications through unofficial channels may lead to adverse reactions and complications.
All therapy decisions should be made individually, taking into account medical history, underlying conditions, and current medications.
